Abstract

After different vaccinations, the study aimed to assess carcass composition, meat quality, and the level of the infectious bursal disease antibody titers in broiler chickens. In the experiment, 4 (30 chicks per group, 120 total) groups of Ross 308 broiler chickens (males and females) were included. Then, they were vaccinated at the hatchery. Group I was immunized against infectious avian bronchitis (IB) and Newcastle disease (ND) using vaccine A (20 mL/100 birds) and vaccine B (20 mL/100 birds), respectively, with injectable vaccine C (0.2 mL/each) targeting Infectious bursal' and Marek's diseases (MD). Group II received the same vaccinations for IB and ND, with separate injectable D vaccines for MD (0.2 mL/unit) and E for infectious bursal' disease (0.2 mL/each). Group III was similarly vaccinated for IB and ND; however, they received only vaccine D (0.2 mL/each) for MD, and on d 23, vaccine F was administered via drinking water against Gumboro disease (0.05 mL/each). Group IV served as the control and was not vaccinated. Ten carcasses from each group on d 42 were taken for carcass composition analysis and meat quality, including pH, color, and water-holding capacity (WHC). During rearing, on d 14, 28, and 42, blood was collected to determine the level of antibodies against infectious bursal' disease. Additionally, hematocrit (HCT), hemoglobin (HGB), and red blood cells were analyzed. In group I, a higher bursa of Fabricius weight than in the other groups was found (P < 0.001), and the liver weight was lower compared to group II (P = 0.020). In breast muscle, the pH24 was higher in the control group than in group I (P = 0.036). Lightness (L*) in breast and leg muscles from group I was higher than in group II (P < 0.05). WHC was higher in group I than in group II (P = 0.025). The antibody titers of infectious bursal' disease was higher in group I on d 28 than in other groups (P < 0.05). Vaccine C (1 dose 0.2 mL/1 bird) of the reconstituted vaccine with the live recombinant virus strain vHVT013-69, not less than 3.6 - 5.0 log10 PFU) had a beneficial effect.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.